Moreover, all COVID-19 patients showed a higher proportion of activated CD69+ exhausted and effector NK subpopulations compared to healthy controls, suggesting elevated cytotoxic activity of CD56dim NK cells. The gene discussed is CD69; the disease is COVID-19.